BioSpace News Archive

Drug Development

Rebiotix Highlights 2017 Achievements and 2018 Objectives

Rebiotix provided a review of its 2017 key business achievements and clinical activities as the company anticipates multiple milestones during 2018 involving its industry-leading MRT drug platform.

January 9, 2018
·
4 min read
Zika Virus Vaccine Shows Significantly Higher Immune Response With Needle-Free Delivery

PharmaJet announced that a recently published study in The Lancet demonstrated that delivery of a Zika virus vaccine with the PharmaJet Stratis.

January 9, 2018
·
2 min read
Business

Cingulate Therapeutics Appoints Experienced Lead Investigator Matthew Brams, MD as CMO

Dr. Brams is a Co-Founder of Cingulate Therapeutics and currently serves as a member of the Board of Directors.

January 9, 2018
·
3 min read
Bedfont Hits the Ground Running in 2018 as it’s Named in Europe’s ‘Ones to Watch’ List

edfont, a second-generation family business that specialises in the design and manufacture of breath analysis medical devices, is proud to announce that it has been named on this list as one of Europe’s best.

January 9, 2018
·
1 min read
Genetown

Lyndra Announces Publication of Feasibility Study of Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy in Nature Communications

Lyndra announced the publication of a feasibility study of an oral, once-weekly drug delivery platform for HIV antiretroviral therapy in the peer-reviewed journal Nature Communications.

January 9, 2018
·
6 min read
Genedata Screener Raises the Bar on Automation in 2018

Genedata today announced that Genedata Screener has been enhanced towards full automation of the planning, execution, and data analysis of screening experiments.

January 9, 2018
·
3 min read
Drug Development

Ziopharm Oncology Provides Update on Standout Technologies During the 36th Annual J.P. Morgan Healthcare Conference

The Company’s corporate presentation at the J.P. Morgan conference is Thursday, Jan. 11, at 10 a.m. PST. T

January 9, 2018
·
9 min read
Alzheimer’s Research UK Release: Top Dementia Research Charity Calls on Pharma to Stay the Course

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.

January 9, 2018
·
1 min read
Drug Development

Incysus Submits Second Investigational New Drug Application for Gamma-Delta T Cell Immunotherapy Candidate

IND to support Phase 1 safety and activity study of Drug Resistant Immunotherapy for the treatment of glioblastoma.

January 9, 2018
·
2 min read
Drug Development

Publication Authored by Researchers at Selecta Biosciences and the National Cancer Institute in PNAS Discusses Restoration of Anti-Tumor Activity of Recombinant Immunotoxin LMB-100 When Combined With SVP-Rapamycin

In the PNAS publication, the authors described preclinical work in which SVP-Rapamycin mitigated the formation of inhibitory ADAs to LMB-100 in both naïve mice and mice pre-exposed to LMB-100, resulting in restoration of LMB-100’s anti-tumor activity.

January 9, 2018
·
5 min read